Pfizer will find a way to mess it all up if they do buy Amarin. They will reorganize the company right after the buyout is complete and completely tank the momentum from the Vascepa launch.
Vascepa looks like the one drug that has come recently that actually has compelling data behind it. Looking at the financial reports, it is on track to exceed its goal for the year.
Pfizer will find a way to screw it up like only Pfizer can
It would be hard to screw up a Lipitor/Vascepa combo. It would be cheaper than Crestor/Vascepa and more effective at reducing LDL, Trigs, & inflamation. The only way this could be messed up is if another BP grabs Vascepa first. $10 billion dollar per year drug potential.